Results for “”

Entry Author Date Location
Bio Roundup: Pelosi’s Reveal, Alder’s Deal, Biogen’s Fails & More 09/20/19 National
Pelosi, Dems Unveil Price Plan: Are 25 Drugs Enough for Negotiation? 09/19/19 National
Why Menlo Ventures Backed Construction Tech Firm Fieldwire 09/16/19 San Francisco
Advisory Body Backs Aimmune Peanut Allergy Drug, Next Up: the FDA 09/13/19 San Francisco
Cloudflare’s $525M IPO Emboldens Already-Confident Internet Booster 09/13/19 San Francisco
Bio Roundup: Award Winners, Lung Data, Dems on Drug Pricing & More 09/13/19 National
SpringWorks and Satsuma Boost This Week’s Biotech IPO Haul to $595M 09/12/19 San Francisco
John Halamka, Livongo Health & AI Progress at X·CON on Oct. 22 09/12/19 Boston
FDA Doesn’t Shell Peanut Allergy Drug Pre-Hearing, Aimmune Shares Climb 09/11/19 San Francisco
After First Look at House Drug Plan, Stocks Rise Slightly 09/10/19 National
Herceptin Inventors, Immunology Pioneers Take Home 2019 Lasker Awards 09/10/19 National
Challenging CRISPR, Trucode Raises $34M for New Gene-Editing System 09/10/19 San Francisco
As New CEO of Cerevel, Coles Moves From One Neuro Startup to Another 09/09/19 Boston
At Big Lung Cancer Meeting, Lights Shine on KRAS, Drug Combos & More 09/09/19 National
Frequency Plans IPO for Hearing Loss Drug & More Regenerative Meds 09/06/19 Boston
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone 09/06/19 National
SF’s Ginger Raises $35M in Burgeoning Digital Therapeutics Market 09/04/19 San Francisco
Bankrupt uBiome Says Founders May Have Misled Investors 09/04/19 San Francisco
Vir Bio Plans IPO to Fund Clinical Trials of Infectious Disease Drugs 09/03/19 San Francisco
As Cholesterol Drug Aces Big Test, MedCo CEO Open to Flexible Pricing 09/02/19 New York
Patent Challenge to Alexion Proceeds, But No Amgen Biosimilar Yet 08/30/19 Boston
Robocalls Crowd Out Real Business Calls. This Startup Has an Answer. 08/30/19 Seattle
Bio Roundup: Cholesterol Check, J&J’s Opioid Hit, AbbVie’s Flop & More 08/30/19 National
$5.8B for Nothing: AbbVie Shelves Stemcentrx Drug After Latest Flop 08/29/19 Detroit Ann Arbor
ThoughtSpot Nabs $248M for Accessible Analytics, Nears $2B Valuation 08/28/19 San Francisco
Celgene to Sell Blockbuster Drug to Amgen for $13B to Close BMS Deal 08/26/19 New York
New PCSK9 Cholesterol Drug Faces Tough Foe. (Hint: Not Cholesterol.) 08/26/19 National
VMware: “We Bought Carbon Black for $2.1B!” Analysts: “Oh… Why?” 08/23/19 Boston
GSK’s Cancer Comeback Continues With Data for Multiple Myeloma Drug 08/23/19 National
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More 08/23/19 National
Page 1 of 195 next page »